Page 85 - 2023 Taiwan Food and Drug Administration Annual Report
P. 85
5Improving Management of Medical
Devices and Cosmetics
▍ Achievements and Benefits TFDA attended the 9th and 10th
periodic joint meetings of CD-P-COS
I. Establishment of testing (European Committee for Cosmetics and
and verification methods for Consumer Health) and OCCLs (European
innovative intelligent medical Network of Official Cosmetics Control
devices Laboratories) in 2022 and discussed with
experts from respective EU states issues such
In response to the needs of the post- as the progress in the joint effort to establish
pandemic era and the populatin aging trend, a methods for testing nitrosamines in cosmetics,
draft method named “Ventilator System Test proficiency test results of whitening cosmetic
and Pressure Relief Test” was drawn in 2022, products, and post-marketing monitoring
which helps ensure the safety and effectiveness results of free formaldehyde in cosmetics, etc.
of ventilators in the country. In light of the Through proactive involvement in events of
rapid developments of AI/ML in the medical international organizations, TFDA strengthens
imaging industry, the draft method for testing collaboration and exchange with official EU
the stability of computer-assisted diagnostic network of cosmetics laboratories, secures
software for ultrasound medical imaging was channels and connections for international
completed in 2022 to help ensure the accuracy communications, and promotes test
of related diagnostic results. technologies for cosmetics in our country to be
in line with international levels.
II. Advancement in test
technologies for cosmetics IV. Enhanced precision
and medical devices medicine molecular testing
quality
Eight testing methods, including the
“Method of Test for Preservatives in Cosmetics As of the end of 2022, a total of
(5),” have been published and 4 methods for 16 precision medicine molecular testing
testing cosmetics, including the “Method of laboratories had been accredited. Most of
Test for Colorants in Cosmetics,” have been them adopt next-generation sequencing
revised, that is, a total of 12 recommended (65%), with test items focusing primarily on
testing methods for 94 items of cosmetics cancer screening, diagnostics, treatment, and
and medical devices have been published or prognostic genetic testing (50%), for the sake
revised in 2022. of improving the quality of molecular testing
in precision medicine.
III. Promotion of international
exchange on test 83
technologies for cosmetics
